BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38122992)

  • 1. sVEGF-R1 in acute non-infectious toxicity syndromes after pediatric allogeneic hematopoietic stem cell transplantation.
    Horan DE; Kielsen K; Weischendorff SW; Sørum ME; Kammersgaard MB; Ifversen M; Nielsen C; Ryder LP; Johansson PI; Müller K
    Transpl Immunol; 2024 Feb; 82():101975. PubMed ID: 38122992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
    Farina M; Scaini MC; Facchinetti A; Leoni A; Bernardi S; Catoni C; Morello E; Radici V; Frioni F; Campodonico E; Traverso G; Cavallaro G; Olivieri A; Galieni P; Renzo ND; Patriarca F; Carluccio P; Skert C; Maffini E; Pellizzeri S; Campisi G; Re F; Benedetti E; Rosato A; Almici C; Chiusolo P; Peccatori J; Malagola M; Poggiana C; Russo D
    Transplant Cell Ther; 2024 Jun; 30(6):580.e1-580.e14. PubMed ID: 38582286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
    Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high-dose chemotherapy: A single-center experience from the Royal Marsden Hospital, UK.
    Roy Moulik N; Johnson I; Van Bruggen L; Petterson T; Mycroft J; Vaidya SJ
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28677. PubMed ID: 32865880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
    Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH).
    González Vicent M; Díaz de Heredia C; González de Pablo J; Molina B; Regueiro A; Pérez Martinez A; Palomo P; López Corral L; García E; Fernández JM; Pérez A; Jiménez MJ; Guerreiro M; Vallejo C; Gallardo AI; López O; Benito A; Marsal J; Duarte M; Bento L; Badell I; Pedraza A; Jiménez Ubieto A; González P; Gómez Centurión I; Costilla L; Beléndez C; Esquirol A; Espigado I; Lavilla E; Díaz MÁ
    Eur J Haematol; 2021 Jun; 106(6):842-850. PubMed ID: 33713387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
    Corbacioglu S; Richardson PG
    Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients.
    Maximova N; Granzotto M; Barbieri F; Marcuzzi A; Tommasini A; Monasta L; Simeone R; Zanon D; Sala R
    Cancer Med; 2019 Mar; 8(3):890-901. PubMed ID: 30690926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of defibrotide in blood and marrow transplantation.
    Richardson PG; Carreras E; Iacobelli M; Nejadnik B
    Blood Adv; 2018 Jun; 2(12):1495-1509. PubMed ID: 29945939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.
    De Ramón Ortiz C; Justo Sanz R; Beauverd Y; Humala K; López de la Guia A; De Paz R; Gasior M; Gómez Prieto P; Fabra Urdiola M; Canales Albendea M; Butta N; Jiménez Yuste V
    Dis Markers; 2023; 2023():7589017. PubMed ID: 37101837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
    Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.
    Picod A; Bonnin A; Battipaglia G; Giannotti F; Ruggeri A; Brissot E; Malard F; Médiavilla C; Belhocine R; Vekhoff A; Gueye MS; Lapusan S; Adaeva R; Isnard F; Legrand O; Baylatry MT; Joly AC; Labopin M; Duléry R; Mohty M
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1471-1475. PubMed ID: 29477779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation.
    Ebbesen M; Weischendorff S; Kielsen K; Kammersgaard M; Juul A; Müller KG
    Bone Marrow Transplant; 2021 May; 56(5):1021-1030. PubMed ID: 33219341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation.
    Park M; Park HJ; Eom HS; Kwon YJ; Park JA; Lim YJ; Yoon JH; Kong SY; Ghim TT; Lee HW; Yun T; Park BK
    Ann Transplant; 2013 Jan; 18():36-42. PubMed ID: 23792499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interest of the preventive and curative use of defibrotide on the occurrence and severity of sinusoidal obstruction syndrome after hematopoietic stem cell transplant in children.
    Rudebeck CJ; Renard C; Halfon-Domenech C; Ouachée-Chardin M; Philippe M; Valla FV; Bertrand Y; Penel-Page M
    EJHaem; 2022 Aug; 3(3):885-893. PubMed ID: 36051041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective Application of Sinusoidal Obstruction Syndrome/Veno-occlusive Disease Diagnostic Criteria in a Pediatric Hematopoietic Stem Cell Transplant Cohort.
    Dhir A; Wadhwa A; Haines H; Chewning J; Murthy S; Kim J; Beatty L; Mixon E; Fowler KB; Gage J; Meadows T; Goldman F
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e343-e348. PubMed ID: 35200220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
    Richardson PG; Triplett BM; Ho VT; Chao N; Dignan FL; Maglio M; Mohty M
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):113-124. PubMed ID: 29301447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric Protocols.
    Salinas Cisneros G; Dvorak CC; Long-Boyle J; Kharbanda S; Shimano KA; Melton A; Chu J; Winestone LE; Dara J; Huang JN; Hermiston ML; Zinter M; Higham CS
    Transplant Cell Ther; 2024 Apr; ():. PubMed ID: 38631464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.